For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Viscosupplementation is a medical treatment for knee osteoarthritis during which lubricating fluid is injected into the knee joint to reduce pain symptoms.
LPI (LP Information)' newest research report, the "Orthopedic Hyaluronic Acid Viscosupplementation Industry Forecast" looks at past sales and reviews total world Orthopedic Hyaluronic Acid Viscosupplementation sales in 2022, providing a comprehensive analysis by region and market sector of projected Orthopedic Hyaluronic Acid Viscosupplementation sales for 2023 through 2029. With Orthopedic Hyaluronic Acid Viscosupplementation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orthopedic Hyaluronic Acid Viscosupplementation industry.
This Insight Report provides a comprehensive analysis of the global Orthopedic Hyaluronic Acid Viscosupplementation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orthopedic Hyaluronic Acid Viscosupplementation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Orthopedic Hyaluronic Acid Viscosupplementation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orthopedic Hyaluronic Acid Viscosupplementation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orthopedic Hyaluronic Acid Viscosupplementation.
The global Orthopedic Hyaluronic Acid Viscosupplementation market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Orthopedic Hyaluronic Acid Viscosupplementation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orthopedic Hyaluronic Acid Viscosupplementation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orthopedic Hyaluronic Acid Viscosupplementation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orthopedic Hyaluronic Acid Viscosupplementation players cover Anika Therapeutics, Sanofi, Zimmer Biomet, Meda, Ferring, Fidia Pharmaceutici and Bioventus, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Orthopedic Hyaluronic Acid Viscosupplementation market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Single Injection
- Three Injection
- Five Injection
Segmentation by application
- Hospitals
- Ambulatory Surgical Centres
- Orthopaedic Clinics
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Anika Therapeutics
- Sanofi
- Zimmer Biomet
- Meda
- Ferring
- Fidia Pharmaceutici
- Bioventus
Key Questions Addressed in this Report
What is the 10-year outlook for the global Orthopedic Hyaluronic Acid Viscosupplementation market?
What factors are driving Orthopedic Hyaluronic Acid Viscosupplementation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orthopedic Hyaluronic Acid Viscosupplementation market opportunities vary by end market size?
How does Orthopedic Hyaluronic Acid Viscosupplementation break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?